Featured Site: Vanderbilt University Medical Center
Please join us on Thursday, August 18th at 5:00 pm EST (4:00pm CST/2:00pm PST) for a webinar about the HEALEY ALS Platform Trial. Sabrina Paganoni, MD, PhD and Merit Cudkowicz, MD, MSc will present updates on the Platform Trial and answer questions from the audience. In addition, this week will feature a special introduction to Site Investigator Amanda Peltier MD, MS, and the study team at Vanderbilt University in Nashville, TN.
|
|
Dr. Peltier is the Site Investigator for the Platform Trial at Vanderbilt University, where she also serves as Chief in the Division of Neuromuscular Disorders. Her research goals are focused on the desire to identify biomarkers to allow for earlier diagnosis.
|
|
